A

AFT Pharmaceuticals Ltd
NZX:AFT

Watchlist Manager
AFT Pharmaceuticals Ltd
NZX:AFT
Watchlist
Price: 2.84 NZD 1.43% Market Closed
Market Cap: 297.8m NZD
Have any thoughts about
AFT Pharmaceuticals Ltd?
Write Note

P/OCF
Price to OCF

11.6
Current
27.2
Median
16.1
Industry
Lower than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
11.6
=
Market Cap
297.8m NZD
/
Operating Cash Flow
25.7m NZD
All Countries
All Countries
Close
Market Cap P/OCF
NZ
AFT Pharmaceuticals Ltd
NZX:AFT
297.8m NZD 11.6
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY -19 905 436.7
US
Eli Lilly and Co
NYSE:LLY
750.9B USD 123.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 6 923.9
DK
Novo Nordisk A/S
CSE:NOVO B
2.8T DKK 23.3
US
Johnson & Johnson
NYSE:JNJ
346.5B USD 13.8
US
Merck & Co Inc
NYSE:MRK
250.3B USD 13.7
CH
Roche Holding AG
SIX:ROG
199.5B CHF 12.4
UK
AstraZeneca PLC
LSE:AZN
161.2B GBP 18.3
CH
Novartis AG
SIX:NOVN
171.3B CHF 11.5
US
Pfizer Inc
NYSE:PFE
149.9B USD 18.6

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A

See Also

Summary
AFT intrinsic value, competitors valuation, and company profile.
DCF Valuation
AFT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AFT stock valuation using valuation multiples.
Wall Street Estimates
AFT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AFT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 210,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.